Epic Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 43 Year, 28 Days
- Last Filing with ROC 31 Mar 2010
- Satisfied Charges ₹ 2.00 M
About Epic Pharmaceuticals
Company Details
-
Location
Satara, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239PN1982PTC026045
-
Company No.
026045
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jan 1982
-
Date of AGM
30 Sep 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Epic Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Dandekar
|
Director | 01-May-2005 | Current |
|
Suyog Dandekar
|
Director | 22-Apr-2004 | Current |
|
Arun Jadhav
|
Director | 22-Apr-2004 | Current |
|
Nanda Jadhav
|
Director | 01-May-2005 | Current |
Financial Performance of Epic Pharmaceuticals.
Enhance accessibility to Epic Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Epic Pharmaceuticals?
Unlock access to Epic Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Bruche Vitals Limited Liability Partners HipSuyog Dandekar is a mutual person
-
Prakruti Ayurvedic Health Resorts Private Limited
Suyog Dandekar and Arun Jadhav are mutual person
-
Forester Entertainments Private Limited
Suyog Dandekar is a mutual person
-
Ajinkya Plastics Private Limited
Arun Jadhav and Nanda Jadhav are mutual person
-
Arya Electromech Private Limited
Arun Jadhav and Nanda Jadhav are mutual person
Charges (Loans)
₹0
₹2.00 M
Charges Breakdown by Lending Institutions
- Janata Sahakari Bank Ltd. : 0.10 Cr
- Dhanwantari Nagari Sahakari Ltd. : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2004 | Dhanwantari Nagari Sahakari Ltd. | ₹1.00 M | Satisfied |
| 08 Feb 2002 | Janata Sahakari Bank Ltd. | ₹1.00 M | Satisfied |
How Many Employees Work at Epic Pharmaceuticals?
Unlock and access historical data on people associated with Epic Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Epic Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epic Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.